Of the primary funding sources for ginseng studies, 67.2% were nonindustry organizations.
Yingchun He, Juan Yang, Yinghua Lv, Junchao Chen, Fang Yin, Jihan Huang, QingshanZheng 2018, 'A Review of Ginseng Clinical Trials Registered in the WHO International Clinical TrialsRegistry Platform', BioMed Research Internationalhttp://dx.doi.org/10.1155/2018/1843142. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
Possible reasons for the differences between nonindustry- and industry-sponsored studies, such as selective reporting of outcomes, require further study.
David Krauth, Andrew Anglemyer, Rose Philipps, Lisa Bero 2014, 'Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimatesthan industry-sponsored studies: a meta-analysis.', PLoS Biologyhttp://europepmc.org/articles/PMC3897361?pdf=render. Retrieved from PLOS CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)